Why Bravura, IOOF, Opthea, & Whispir shares stormed higher today

The IOOF Holdings Limited (ASX:IFL) share price and the Opthea Ltd (ASX:OPT) share price are two of four storming notably higher today…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It looks set to be a disappointing end to the week for the S&P/ASX 200 index. In afternoon trade the benchmark index is trading 0.6% lower at 6,643.1 points.

Four shares that have not let that hold them back are listed below. Here's why they are ending the week on a high:

The Bravura Solutions Ltd (ASX: BVS) share price has jumped 7% to $4.02 despite there being no news out of it. However, the shares of the provider of software products and services to the wealth management and funds administration industries are trading notably lower than their 52-week high. This could mean that bargain hunters are swooping in today to pick up shares at an attractive price.

The IOOF Holdings Limited (ASX: IFL) share price has climbed 3.5% to $7.31. The catalyst for today's gain has been news that APRA will not be appealing the recent Federal Court ruling. Last month the Court held that IOOF's APRA regulated entities and five employees did not contravene the Superannuation Industry Act 1993. This is the second consecutive day of strong gains. On Thursday IOOF's shares raced higher following a positive update on its acquisition of the Australia and New Zealand Banking Group (ASX: ANZ) Wealth Pension and Investments business.

The Opthea Ltd (ASX: OPT) share price has stormed 5.5% higher to $3.51. Investors have been buying the biotech company's shares after the release of a positive broker note out of Goldman Sachs. This morning it reiterated its (conviction) buy rating and lifted its price target to $5.20. Recent events mean the broker sees a clearer path to a favourable Phase III outcome and ultimately a greater chance of approval for OPT-302. OPT-302 is a combination therapy for treatment-naïve patients with wet age-related macular degeneration (AMD). The broker believes it has a ~US$10 billion market opportunity.

The Whispir Limited (ASX: WSP) share price has been a strong performer and is up 9% to $1.68. This morning the software-as-a-service communications workflow platform provider released its first quarter update. According to the release, Whispir has started FY 2020 strongly, with quarterly Annualised Recurring Revenue of $34.5 million. This was a 10% increase since the end of June and puts Whispir ahead of its prospectus forecast.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. The Motley Fool Australia has recommended Whispir Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »